Results 161 to 170 of about 4,368 (233)

Pegvisomant treatment in acromegaly in clinical practice: final results of the French ACROSTUDY (312 patients).

Annales d'Endocrinologie, 2021
S. Barraud, P. Caron, I. Raingeard, H. Lefebvre, G. Raverot, C. Cortet-Rudelli, R. Desailloud, Robin Henocque, Y. Brault, T. Brue, P. Chanson, B. Delemer   +11 more
semanticscholar   +1 more source

Impact of Medical Therapies on Cardiovascular Risk Factors in Acromegaly. [PDF]

Cureus
Wekesa R, Chatterjee S, Alhiraki O, Sheikh A.   +3 more
europepmc   +1 more source

Combined treatment with octreotide LAR and pegvisomant in patients with gigantism - acromegaly: clinical evaluation and genetic screening [PDF]

, 2016
Liliya Rostomyan, Ruth Mangupli, Emilie Castermans, Jean-Hubert Caberg, Paul Camperos, Elvia Cuauro, Vincent Bours, Adrian Daly, Albert Beckers   +8 more
openalex   +1 more source

Pegvisomant-Induced Liver Injury Is Related to the UGT1A1*28 Polymorphism of Gilbert’s Syndrome [PDF]

, 2010
Ignacio Bernabéu, Mónica Marazuela, Tomás Lúcas, Lourdes Loidi, Cristina Álvarez‐Escolá, Manuel Luque‐Ramírez, Eva Fernández-Rodríguez, Amalia-Elisa Paniagua, Celsa Quinteiro, Felipe F. Casanueva   +9 more
openalex   +1 more source

Adherence, duration and healthcare costs in a real-world population of patients with acromegaly. [PDF]

J Comp Eff Res
Quock TP, Chang E, Das AK, Speller A, Tarbox MH, Rattana SK, Paulson IE, Broder MS.   +7 more
europepmc   +1 more source

PDB89 COST-EFFECTIVENES ANALYSIS OF USING PEGVISOMANT FOR TREATMENT OF ACROMEGALY IN RUSSIA [PDF]

, 2019
NA Avxentyev, M. Yu. Frolov, A. Yu. Makarov   +2 more
openalex   +1 more source

Regulation of growth-hormone-receptor gene expression by growth hormone and pegvisomant in human mesangial cells [PDF]

, 2003
Udo Meinhardt, Andrée Eblé, Amélie Besson, Christian J. Strasburger, Jean–Daniel Sraer, Primus E. Mullis   +5 more
openalex   +1 more source

Management of patients with acromegaly in clinical practice in the gulf countries: a Delphi consensus survey. [PDF]

Front Endocrinol (Lausanne)
Almalki MH, Elhadd T, AlDahmani KM, Ekhzaimy A, Alqanaei A, Frookh H, Alyamani A, Hakami O, Dabbous Z, Rohani Z, Almistehi W, Aljumah H, Alfutaisi A, Bashier A, Mahzari M.   +14 more
europepmc   +1 more source

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes [PDF]

, 2013
Antonio Bianchi, Ferdinando Valentini, R Iuorio, Maurizio Poggi, Roberto Baldelli, M. Passeri, Antonella Giampietro, Linda Tartaglione, Sabrina Chiloiro, Marialuisa Appetecchia, Patrizia Gargiulo, Andrea Fabbri, Vincenzo Toscano, Alfredo Pontecorvi, Laura De Marinis   +14 more
openalex   +1 more source

Interventions to slow aging in humans: Are we ready? [PDF]

, 2015
et al,, Klein, Samuel
core   +1 more source